A technique known as metabolomics may enable an Alzheimer's disease blood test diagnosis before patients start displaying symptoms, Mayo Clinic scientists have concluded.
An experimental drug designed to block an overactive protein in kidney cancer may provide a more targeted approach to treating the common cancer and could eventually be used as a therapy for other types of the disease.
After scaling back its IPO price by about 85%, diagnostics outfit Cancer Genetics has some good news to report, pulling in $6.9 million once its under-writers exercised their over-allotment option.
With great fanfare, the Mayo Clinic won FDA approval late last year for a new diagnostic imaging agent that helps determine when prostate cancer has returned. But as Bloomberg reports, the non-profit medical center has struggled to expand access to the compound.
Two top research organizations have mounted a combined effort to discover new drugs for cancer, Alzheimer's disease and other illnesses.
Investigators from the Mayo Clinic say a recent study helped uncover two new biomarkers for acute kidney injury which should flag at-risk patients significantly earlier than currently used biomarkers.
California's SV Bio announced its presence to the world last week, and now the forward-thinking diagnostics outfit is partnering with the Mayo Clinic to bring clinical genome interpretation to Mayo's Center for Individualized Medicine.
With the 5-year survival rate for pancreatic cancer at just 6%--the lowest among all major killer cancers--finding a treatment for the disease could literally be lifesaving for patients.
As head of the Pentagon's $250 million project on regenerative medicine, Dr. Joachim Kohn has pioneered several new technologies: degradable compounds for drug delivery, the use of polymers and tissue scaffolds to create new body parts or rebuild bone and nerves in war-damaged soldiers.
Mayo Clinic scientists believe they've found an enzyme that could defeat Alzheimer's disease by destroying the brain-clogging protein that is a hallmark of the condition as it advances.